HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α
- 7 February 2020
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 39 (14) , 2863-2876
Abstract
Aberrant angiogenesis of hepatocellular carcinoma (HCC) leads to tumor growth and local or distant metastasis. Uncovering the underlying mechanisms for the neoangiogenesis of HCC can provide novel potential therapeutic targets in the clinic. Here, we reported that serine/threonine homeodomain-interacting protein kinase 2 (HIPK2) was frequently downregulated in HCC tissues compared with the adjacent normal tissues, and patients with lower HIPK2 protein expression were associated with worse overall survival. Both in vitro and in vivo, HIPK2 inhibited the migration of HCC cells, as well as tumor growth and metastasis in xenograft and orthotopic syngeneic HCC mouse models. Furthermore, HIPK2 inhibited the angiogenesis in HCC tumors. Under the hypoxic condition, HIPK2 knockdown enhanced the angiogenesis and the key regulator, HIF-1α signaling pathway; however, HIPK2 overexpression downregulated the tumoral angiogenesis and HIF-1α signaling. In HCC cells, HIPK2 could directly bind to HIF-1α and stimulate the ubiquitination of HIF-1α for proteasomal degradation. HIF-1α knockout partially rescued the promoting effect of HIPK2 depletion on angiogenesis and tumor growth. In conclusion, the downregulation of HIPK2 could enhance the angiogenesis in HCC through inducing the HIF-1α pathway, and further contribute to tumor growth and metastasis, which may provide a novel therapeutic strategy for HCC.Keywords
Funding Information
- National Natural Science Foundation of China (81630086, 81427805, 81573161, 81973078)
- Science and Technology Commission of Jiading District
This publication has 44 references indexed in Scilit:
- Targeting COX-2/PGE2 Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell MaturationPLOS ONE, 2012
- Transcatheter Arterial Chemoembolization: History for More than 30 YearsISRN Gastroenterology, 2012
- HCC and angiogenesis: possible targets and future directionsNature Reviews Clinical Oncology, 2011
- Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosisMolecular Cancer, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- HIPK2 inhibits both MDM2 gene and protein by, respectively, p53‐dependent and independent regulationsFEBS Letters, 2005
- Inactivating mutations of the Siah-1 gene in gastric cancerOncogene, 2004
- HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic functionOncogene, 2004
- Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functionsExperimental & Molecular Medicine, 2004
- Identification and Characterization of HIPK2 Interacting with p73 and Modulating Functions of the p53 Familyin VivoJournal of Biological Chemistry, 2002